Showing results (61-70 of 117) with videos related to
Sort By:
Pageof 12
Haematologica|December 11, 2025
Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical studyKudret Kama, Hannes Treiber, Alexandra Kutilina, et al.Neuro-Oncology Practice|June 9, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastomaJohn Y Rhee, Carissa Mastrangelo, Paul J Miller, et al.Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002Andrés J M Ferreri, Lauren E Abrey, Jean-Yves Blay, et al.Frontiers in Immunology|July 26, 2021
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic LeukemiaAnnika Nelde, Yacine Maringer, Tatjana Bilich, et al.The Journal of Molecular Diagnostics : JMD|August 4, 2020
Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral BiopsyManuel Montesinos-Rongen, Anna Brunn, Armin Tuchscherer, et al.BMC Cancer|June 19, 2023
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, et al.Journal of Neuro-Oncology|May 8, 2010
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasDavid M Peereboom, Jeffrey G Supko, Kathryn A Carson, et al.Haematologica|January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantationElisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.Cancer|April 21, 2012
A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)L Burt Nabors, Thomas Mikkelsen, Monika E Hegi, et al.Pageof 12